H. Nagase, S. Takagahara, Y. Satomi, A. . Ando, K. Kubo, and S. Ikeda, “Effects of compound-326, a selective delta-5 desaturase inhibitor, in ApoE knockout mice with two different protocols for atherosclerosis development”, J Pharm Pharm Sci, vol. 24, pp. 71–83, Feb. 2021.